According to a recent LinkedIn post from Cirsium Biosciences, the company is in the process of shifting an early-stage seeding step in its workflow from manual handling to automation. The post describes how seed placement currently takes hours and is performed carefully by hand, but is expected to transition to an automated system in the coming weeks, reducing the process to minutes.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that this move toward automation is intended to increase speed, consistency, and scalability while preserving the precision of the existing manual process. For investors, this focus on automating a critical bottleneck may indicate an effort to improve throughput, reduce labor intensity, and lay groundwork for higher-volume operations, which could enhance margins and support future commercial scaling if the underlying technology gains market traction.